On the other hand, the enhanced migratory response of HER2/neu+ tumor cells to SAA1, SAA2, and THBS4 (Fig. 4c, d) suggests that stromal mutant p53 may predispose tumors to metastasis at earlier stages. This evidence concerns the gene ERBB2 and neoplasm.